Aoyama, Y.; Naiki-Ito, A.; Xiaochen, K.; Komura, M.; Kato, H.; Nagayasu, Y.; Inaguma, S.; Tsuda, H.; Tomita, M.; Matsuo, Y.;
et al. Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model. Nutrients 2022, 14, 42.
https://doi.org/10.3390/nu14010042
AMA Style
Aoyama Y, Naiki-Ito A, Xiaochen K, Komura M, Kato H, Nagayasu Y, Inaguma S, Tsuda H, Tomita M, Matsuo Y,
et al. Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model. Nutrients. 2022; 14(1):42.
https://doi.org/10.3390/nu14010042
Chicago/Turabian Style
Aoyama, Yoshinaga, Aya Naiki-Ito, Kuang Xiaochen, Masayuki Komura, Hiroyuki Kato, Yuko Nagayasu, Shingo Inaguma, Hiroyuki Tsuda, Mamoru Tomita, Yoichi Matsuo,
and et al. 2022. "Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model" Nutrients 14, no. 1: 42.
https://doi.org/10.3390/nu14010042
APA Style
Aoyama, Y., Naiki-Ito, A., Xiaochen, K., Komura, M., Kato, H., Nagayasu, Y., Inaguma, S., Tsuda, H., Tomita, M., Matsuo, Y., Takiguchi, S., & Takahashi, S.
(2022). Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model. Nutrients, 14(1), 42.
https://doi.org/10.3390/nu14010042